Adel S El-Azab

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Molecules (Basel, Switzerland)

RSC advances

King Saud University College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

King Saud University College of Pharmacy

Saudi Arabia

Professor :: Pharmaceutical Chemistry

Publications

Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, Abdullah A Elgazar, Hamed W El-Shafey, Adel S El-Azab, Ahmed H Bakheit, Mohamed M Hefnawy, Hazem A Ghabour, Alaa A-M Abdel-Aziz
S -Alkylated quinazolin-4(3 H )-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study. RSC advances 14 (36) (2024)
Samar S Tawfik, Abdelrahman Hamdi, Ahmed R Ali, Abdullah A Elgazar, Hamed W El-Shafey, Adel S El-Azab, Ahmed H Bakheit, Mohamed M Hefnawy, Hazem A Ghabour, Alaa A-M Abdel-Aziz
S -Alkylated quinazolin-4(3 H )-ones as dual EGFR/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study. RSC advances 14 (36) (2024)
Alaa A-M Abdel-Aziz, Adel S El-Azab, Simone Brogi, Rezk R Ayyad, Hamad M Al Kahtani, Hatem A Abuelizz, Ibrahim A Al-Suwaidan, Abdulrahman M Al-Obaid
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis. RSC advances 14 (31) (2024)
Alaa A-M Abdel-Aziz, Adel S El-Azab, Simone Brogi, Rezk R Ayyad, Hamad M Al Kahtani, Hatem A Abuelizz, Ibrahim A Al-Suwaidan, Abdulrahman M Al-Obaid
Synthesis, enzyme inhibition assay, and molecular modeling study of novel pyrazolines linked to 4-methylsulfonylphenyl scaffold: antitumor activity and cell cycle analysis. RSC advances 14 (31) (2024)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Adel S El-Azab, Alaa A-M Abdel-Aziz, Hazem A Ghabbour, Silvia Bua, Alessio Nocentini, Hamad M Al Kahtani, Nawaf A Alsaif, Mohamed H M Al-Agamy, Claudiu T Supuran
Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked Benzenesulfonamide. Molecules (Basel, Switzerland) 27 (22) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Mohamed M Hefnawy, A F M Motiur Rahman, Abdullah M Al-Hossaini, Abdulaziz I Alnasser, Adel S El-Azab, Yousef A Bin Jardan, Mohamed W Attwa, Manal A El-Gendy
A Rapid and Sensitive Liquid Chromatography-Tandem Mass Spectrometry Bioanalytical Method for the Quantification of Encorafenib and Binimetinib as a First-Line Treatment for Advanced (Unresectable or Metastatic) Melanoma-Application to a Pharmacokinetic Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Salma Fares, Khalid B Selim, Fatma E Goda, Magda A A El-Sayed, Nawaf A AlSaif, Mohamed M Hefnawy, Alaa A-M Abdel-Aziz, Adel S El-Azab
Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Alaa A-M Abdel-Aziz, Adel S El-Azab, Nawaf A Alsaif, Ahmad J Obaidullah, Abdulrahman M Al-Obaid, Ibrahim A Al-Suwaidan
Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study. Journal of enzyme inhibition and medicinal chemistry 36 (1) (2021)
Ashraf N Abdalla, Mohamed E Abdallah, Akhmed Aslam, Ammar Bader, Antonio Vassallo, Nunziatina De Tommasi, Waleed H Malki, Ahmed M Gouda, Mohammed H Mukhtar, Mahmoud Zaki El-Readi, Hamad M Al Kahtani, Alaa A-M Abdel-Aziz, Adel S El-Azab
Synergistic Anti Leukemia Effect of a Novel Hsp90 and a Pan Cyclin Dependent Kinase Inhibitors. Molecules (Basel, Switzerland) 25 (9) (2020)
Walaa M El-Husseiny, Magda A A El-Sayed, Adel S El-Azab, Nawaf A AlSaif, Mohammed M Alanazi, Alaa A-M Abdel-Aziz
Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Adel S El-Azab, Alaa A-M Abdel-Aziz, Hany E A Ahmed, Sivia Bua, Alessio Nocentini, Nawaf A AlSaif, Ahmad J Obaidullah, Mohamed M Hefnawy, Claudiu T Supuran
Exploring structure-activity relationship of S-substituted 2-mercaptoquinazolin-4(3H)-one including 4-ethylbenzenesulfonamides as human carbonic anhydrase inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Adel S El-Azab, Alaa A-M Abdel-Aziz, Silvia Bua, Alessio Nocentini, Nawaf A AlSaif, Mohammed M Alanazi, Manal A El-Gendy, Hany E A Ahmed, Claudiu T Supuran
S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2020)
Magda A A El-Sayed, Walaa M El-Husseiny, Naglaa I Abdel-Aziz, Adel S El-Azab, Hatem A Abuelizz, Alaa A-M Abdel-Aziz
Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Adel S El-Azab, Alaa A-M Abdel-Aziz, Laila A Abou-Zeid, Walaa M El-Husseiny, Ahmad M El Morsy, Manal A El-Gendy, Magda A A El-Sayed
Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Walaa M El-Husseiny, Magda A A El-Sayed, Naglaa I Abdel-Aziz, Adel S El-Azab, Esam R Ahmed, Alaa A-M Abdel-Aziz
Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)

Adel S El-Azab.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adel S El-Azab